摘要
目的分析左氧氟沙星在治疗幽门螺杆菌感染中的应用价值。方法选取2016年1月至2017年9月期间于我院就诊的78例幽门螺杆菌感染病患,随机分为两组,各39例。对照组患者选用传统三联疗法(雷贝拉唑、阿莫西林、克拉霉素),研究组患者应用三联疗法时用左氧氟沙星替代阿莫西林,对比治疗效果。结果研究组治疗总有效率高于对照组(P<0.05);不良反应发生率低于对照组(P>0.05)。结论左氧氟沙星治疗幽门螺杆菌感染疗效佳、安全性高,可推广应用。
Objective To analyze the value of levofloxacin in the treatment of Helicobacter pylori infection. Methods 78 cases of Helicobacter pylori infection in our hospital from January 2016 to September 2017 were randomly divided into two groups,39 cases in each group. The patients in the control group were treated with traditional triple therapy( Rebela,amoxicillin and clarithromycin). The patients in the study group used levofloxacin instead of amoxicillin with triple therapy and compared the therapeutic effect. Results The total effective rate of the study group was higher than that of the control group( P < 0. 05),and the incidence of adverse reactions was lower than that of the control group( P>0. 05). Conclusion levofloxacin is effective and safe in the treatment of Helicobacter pylori infection,and it can be widely applied.
关键词
幽门螺杆菌
感染
左氧氟沙星
三联疗法
helicobacter pylori
infection
levofloxacin
triple therapy
